Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Kamboj, Mini ; Brite, Jennifer ; Aslam, Anoshe ; Kennington, Jessica ; Babady, N. Esther ; Calfee, David ; Furuya, Yoko ; Chen, Donald ; Augenbraun, Michael ; Ostrowsky, Belinda ; Patel, Gopi ; Mircescu, Monica ; Kak, Vivek ; Tuma, Roman ; Karre, Teresa A. ; Fry, Deborah A. ; Duhaney, Yola P. ; Moyer, Amber ; Mitchell, Denise ; Cantu, Sherry ; Hsieh, Candace ; Warren, Nancy ; Martin, Stacy ; Willson, Jill ; Dickman, Jeanne ; Knight, Julie ; Delahanty, Kim ; Flood, Annemarie ; Harrington, Jennifer ; Korenstein, Deborah ; Eagan, Janet ; Sepkowitz, Kent
• Description:
  In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency.
• Subjects:
  Bacteriological Techniques Clostridium Difficile/genetics Clostridium Infections/diagnosis Clostridium Infections/epidemiology Clostridium Infections/microbiology Dispatch Health Status Disparities Hospitalization Hospitals Humans Nucleic Acid Amplification Techniques Public Health Surveillance

  More +
• Source:
  Emerg Infect Dis. 24(3):584-587.
• Pubmed ID:
  29460760
• Pubmed Central ID:
  PMC5823336
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Location:
  North America
• Volume:
  24
• Issue:
  3
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:a8ff3364f506311ba936f1d1c1bb801859d149f4bbb3043f37fedc5f6d8f370d
• Download URL:
  https://stacks.cdc.gov/view/cdc/52185/cdc_52185_DS1.pdf
• File Type:
  [PDF - 1.06 MB ]